VIP Gloves Limited (ASX:VIP) Secures RM2.75 Million Short Term Loan Ahead of Share Placement
VIP Gloves Limited (ASX:VIP) secures RM2.75 million short-term loan ahead of its share placement and potential ASX delisting.
CLINUVEL Pharmaceuticals Limited (ASX:CUV) Reports Preliminary CUV052 Study Results
CLINUVEL (ASX:CUV) releases preliminary results from the CUV052 study, supporting SCENESSE®’s safety in adolescent EPP patients.
Smartgroup Corporation Ltd (ASX:SIQ) Secures Monash Health Contract for Salary Packaging
Smartgroup Corporation Ltd (ASX:SIQ) secures a contract with Monash Health to provide salary packaging and novated leasing services for 25,000 employees.
Nagambie Resources (ASX:NAG) Announces Research Findings on Whroo Project
Nagambie Resources (ASX:NAG) reports significant research findings on its Whroo Project, highlighting high-grade antimony and gold assays.
Albion Resources Limited (ASX:ALB) Identifies New Priority Gold Targets
Albion Resources (ASX:ALB) identifies significant new gold targets at Yandal West, highlighting exploration potential and upcoming drilling plans.
Terramin Australia Ltd (ASX:TZN) Updates on Bird in Hand Gold Project Appeal
Terramin Australia (ASX:TZN) updates on the legal appeal and operational progress of its Bird in Hand Gold Project, highlighting significant economic benefits for South Australia.
Red Metal Limited (ASX:RDM) Confirms Sybella Rare Earth Discovery Continuity
Red Metal Limited (ASX:RDM) confirms the strong continuity of its Sybella rare earth discovery through infill drilling, enhancing resource confidence.
Patronus Resources Limited (ASX:PTN) Announces Takeover Offer for Matsa Resources (ASX:MAT)
Patronus Resources (ASX:PTN) announces a $0.045 per share takeover offer for Matsa Resources (ASX:MAT), providing a significant premium and immediate liquidity for shareholders.
Trek Metals Limited (ASX:TKM) Announces High-Grade Manganese Discovery
Trek Metals Limited (ASX:TKM) announces high-grade manganese discoveries at Pearana Prospect, highlighting strong exploration results and future drill plans.
PYC Therapeutics (ASX:PYC) Receives Approval to Begin Human Trials for PKD Treatment
PYC Therapeutics (ASX:PYC) receives regulatory approval to commence human trials for its PKD drug candidate, PYC-003.